ECILC Stock Overview
Together with subsidiaries, engages in health and real estate development businesses primarily in Turkey.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₺40.24 |
52 Week High | ₺64.80 |
52 Week Low | ₺38.84 |
Beta | -0.15 |
11 Month Change | -17.41% |
3 Month Change | -24.15% |
1 Year Change | -30.98% |
33 Year Change | 597.40% |
5 Year Change | 1,206.49% |
Change since IPO | 867,889.65% |
Recent News & Updates
Recent updates
Shareholder Returns
ECILC | TR Personal Products | TR Market | |
---|---|---|---|
7D | -13.8% | 0.9% | -8.0% |
1Y | -31.0% | 8.8% | 1.0% |
Return vs Industry: ECILC underperformed the TR Personal Products industry which returned 8.8% over the past year.
Return vs Market: ECILC underperformed the TR Market which returned 1% over the past year.
Price Volatility
ECILC volatility | |
---|---|
ECILC Average Weekly Movement | 6.4% |
Personal Products Industry Average Movement | 6.2% |
Market Average Movement | 6.3% |
10% most volatile stocks in TR Market | 9.7% |
10% least volatile stocks in TR Market | 4.9% |
Stable Share Price: ECILC has not had significant price volatility in the past 3 months compared to the TR market.
Volatility Over Time: ECILC's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1951 | 1,137 | Muge Satir | www.eis.com.tr |
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses primarily in Turkey. The Health segment produces and sells human health and veterinary drugs, as well as engages in pharmaceutical sales and marketing. The Real Estate Development segment develops real estate properties; engages in leasing activities for facilities; and provides consulting services regarding land development and project management.
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. Fundamentals Summary
ECILC fundamental statistics | |
---|---|
Market cap | ₺27.57b |
Earnings (TTM) | ₺2.24b |
Revenue (TTM) | ₺5.90b |
12.3x
P/E Ratio4.7x
P/S RatioIs ECILC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ECILC income statement (TTM) | |
---|---|
Revenue | ₺5.90b |
Cost of Revenue | ₺4.07b |
Gross Profit | ₺1.83b |
Other Expenses | -₺403.09m |
Earnings | ₺2.24b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 3.26 |
Gross Margin | 31.07% |
Net Profit Margin | 37.90% |
Debt/Equity Ratio | 7.7% |
How did ECILC perform over the long term?
See historical performance and comparison